<DOC>
	<DOCNO>NCT02561884</DOCNO>
	<brief_summary>To demonstrate bioequivalence Olostar Tab versus two co-administered reference IMPs Olmetec Crestor .</brief_summary>
	<brief_title>A Single-dose , Randomized , Two-period , Two-treatment , Two-sequence , Crossover Bioequivalence Study Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil Rosuvastatin Calcium Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<criteria>BMI ≥ 18.5 ≤ 30.0 kg/m2 . No clinically significant finding 12lead electrocardiogram ( ECG ) Age 1860 year screen History severe allergy allergic reaction IMPs relate drug History serious clinical illness impact fate drug include major surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>